Long ‐term experience with intranasal bevacizumab therapy

ConclusionsIntranasal bevacizumab injection is an effective treatment for most of the moderate and severe grades of HHT‐associated epistaxis. The duration of the effect of the treatment was variable. Primary and late resistance phenomena to the treatment were quite common. Level of Evidence4. Laryngoscope, 2018

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Flary.27147

Source: The Laryngoscope - February 22, 2018 Category: ENT & OMF Authors: Johan Steineger, Terje Osnes, Ketil Heimdal, Sinan Dheyauldeen Tags: Allergy/Rhinology Source Type: research